Literature DB >> 6736975

Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.

R G Brown, C D Marsden, N Quinn, M A Wyke.   

Abstract

Sixteen patients with idiopathic Parkinson's disease were selected who were all showing severe fluctuations in motor function ("on-off" phenomenon). Measures of cognitive function and of subjective affect/arousal state were taken on two occasions, once when "on" and once when "off". Twenty-five matched normal controls were also assessed on the same measures. Results revealed, on the average, a drop in cognitive function plus an adverse swing in affect/arousal state, in the patient group in the "off" condition, compared to the levels when "on". Analysis of the data suggested that the main factor associated with cognitive function when "off" was not the severity of disability but the level of affect/arousal. The fluctuations in cognitive function found tended to be mild relative to the severe changes in motor ability, and were present in only a proportion of patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6736975      PMCID: PMC1027819          DOI: 10.1136/jnnp.47.5.454

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  39 in total

1.  Anatomical and chemical studies of a nigro-neostriatal projection in the cat.

Authors:  R Y Moore; R K Bhatnagar; A Heller
Journal:  Brain Res       Date:  1971-07-09       Impact factor: 3.252

2.  Mental symptoms in Parkinsonian patients treated with L-dopa.

Authors:  R B Jenkins; R H Groh
Journal:  Lancet       Date:  1970-07-25       Impact factor: 79.321

3.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

4.  Cerebral atrophy in Parkinsonism.

Authors:  G Selby
Journal:  J Neurol Sci       Date:  1968 May-Jun       Impact factor: 3.181

5.  Intellectual functioning of persons with idiopathic Parkinsonism.

Authors:  D C Garron; H L Klawans; F Narin
Journal:  J Nerv Ment Dis       Date:  1972-06       Impact factor: 2.254

6.  Parkinsonism and depression.

Authors:  G L Brown; W P Wilson
Journal:  South Med J       Date:  1972-05       Impact factor: 0.954

7.  L-dopa in the treatment of post-surgical Parkinson patients.

Authors:  H T Wycis; W Cunningham; G Kellett; E A Spiegel
Journal:  J Neurosurg       Date:  1970-03       Impact factor: 5.115

8.  Intellectual changes associated with levodopa therapy.

Authors:  M J Meier; W E Martin
Journal:  JAMA       Date:  1970-07-20       Impact factor: 56.272

9.  Physical disability and mental health in old age. A follow-up of a random sample of elderly people seen at home.

Authors:  D W Kay; K Bergmann
Journal:  J Psychosom Res       Date:  1966-07       Impact factor: 3.006

10.  Memory disturbance and the Parkinson syndrome.

Authors:  J W Warburton
Journal:  Br J Med Psychol       Date:  1967-06
View more
  25 in total

1.  Cognitive components of reaction time in Parkinson's disease.

Authors:  N Jordan; H J Sagar; J A Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

2.  Relations between on-off phenomena and cognitive functions in Parkinson disease.

Authors:  G Meco; V Bonifati; L Bedini; A Bellatreccia; N Vanacore; A Franzese
Journal:  Ital J Neurol Sci       Date:  1991-02

Review 3.  Deterioration of dopaminergic pathways and alterations in cognition and motor functions.

Authors:  B Dubois; B Pillon; Y Agid
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

4.  A component analysis of the generation and release of isometric force in Parkinson's disease.

Authors:  N Jordan; H J Sagar; J A Cooper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 5.  Depression in Parkinson's disease.

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

6.  Cognitive improvement during Tolcapone treatment in Parkinson's disease.

Authors:  M Gasparini; E Fabrizio; V Bonifati; G Meco
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans.

Authors:  M Onofrj; M F Ghilardi; M Basciani; D Gambi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

8.  Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

Authors:  B Pillon; B Dubois; G Cusimano; A M Bonnet; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 9.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 10.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.